XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings (Loss) Per Share
6 Months Ended
Apr. 01, 2022
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE:
Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedSix Months Ended
April 1, 2022April 2, 2021April 1, 2022April 2, 2021
Earnings (Loss):
Net income (loss) attributable to Aramark
stockholders
$35,748 $(77,576)$78,359 $(158,819)
Shares:
Basic weighted-average shares outstanding
257,100 254,508 256,785 254,088 
Effect of dilutive securities(1)
1,647 — 1,614 — 
Diluted weighted-average shares outstanding
258,747 254,508 258,399 254,088 
Basic Earnings (Loss) Per Share:
Net income (loss) attributable to Aramark
stockholders
$0.14 $(0.30)$0.31 $(0.63)
Diluted Earnings (Loss) Per Share:
Net income (loss) attributable to Aramark
stockholders
$0.14 $(0.30)$0.30 $(0.63)
(1)
Incremental shares of 2.2 million and 2.0 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and six months ended April 2, 2021, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods.
Share-based awards to purchase 9.7 million and 9.2 million shares were outstanding for the three months ended April 1, 2022 and April 2, 2021, respectively, but were not included in the computation of diluted earnings (loss) per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.0 million and 1.1 million shares were outstanding for the three months ended April 1, 2022 and April 2, 2021, respectively, but were not included in the computation of diluted earnings (loss) per common share, as the performance targets were not yet met.
Share-based awards to purchase 9.6 million and 11.6 million shares were outstanding for the six months ended April 1, 2022 and April 2, 2021, respectively, but were not included in the computation of diluted earnings (loss) per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.0 million and 1.1 million shares were outstanding for the six months ended April 1, 2022 and April 2, 2021, respectively, but were not included in the computation of diluted earnings (loss) per common share, as the performance targets were not yet met.